Merck's Good Cholesterol Battle
87010
New data are due out on a promising cholesterol drug. But there are doubters.
73292
Federal advisers rejected Merck &amp; Co.'s quest to become the first American drug maker to sell cholesterol-fighting statins over the counter, saying the company's own studies raised potential health risks while offering modest life-saving benefits.
237641
Treating heart-attack patients without losing any time and with a more aggressive regimen of cholesterol-lowering medicines can save many lives, shows new research.
243682
Uh-oh, your lab results are back and your cholesterol's in the danger zone. Your doctor has given you an ultimatum: Start exercising and watch your diet or you'll have to start taking a cholesterol-busting statin drug. Millions of American adults are being handed the same marching orders -- whip those cholesterol numbers into shape or go on a prescription medication.
562923
Merck will have a strong sales pitch for Cordaptive, even if it doesn't convince the skeptics.
22206
Internal e-mails and other documents from Merck &amp; Co. show the company fought for years to keep safety concerns from undermining the drug&#39;s commercial prospects, the Wall Street Journal reported on Monday.
601664
NEW YORK  - A moderately high total   cholesterol level approaching 200 mg/dL is associated with   higher survival in patients with heart failure than levels   below 140 mg/dL, according to a report.
46018
NEW YORK  - For people with low levels of  "good" (HDL) cholesterol and coronary disease, treatment aimed  at increasing HDL levels is worthwhile, researchers report.
598332
The FDA will review its new cholesterol drug.
723523
A long-acting niacin drug that  raises so-called good cholesterol showed promise in slowing the  clogging of arteries when taken along with cholesterol-lowering  statins compared to statin therapy alone, according to a small  clinical study.
545292
Science & environment: Drug that boosts ability to lower cholesterol could help guard against heart attacks, research shows
32044
High doses of Zocor provide no benefits in preventing new problems in heart attack patients: study. MUNICH  - Merck&#39;s anti-cholesterol drug Zocor suffered a setback after a major study found high
675656
Now that Merck &amp; Co. has removed its arthritis painkiller Vioxx from the market after tests found that it increased the risk of heart attacks and strokes, its rival Pfizer is taking a surprising stance.
167795
There are some indications that statins arenât all theyâre cracked up to be.
759985
The government is questioning if too many of the wrong people will take cholesterol-lowering Mevacor if it's sold without a prescription, days before Merck & Co. makes its third try to move the drug over the counter.
633533
NEW YORK  - Levels of high-density  lipoprotein (HDL), the "good" cholesterol, are inversely  associated with stroke risk in elderly men, according to a new  study.
207329
Merck & Co's combination pill to raise "good" HDL cholesterol with less facial flushing -- a common side effect of HDL drugs -- met its main goals in a late-stage test, researchers said on Sunday.